Key result
Impella devices are associated with systemic and mechanical complications, and their use in high-risk percutaneous coronary intervention is based on very limited data.
Highlights the limited data supporting the use of percutaneous left ventricular assist devices in high-risk PCI and associated complications.
The article by Khalid et al highlights the important complications associated with the Impella® devices (Abiomed, Danvers, MA, USA) that are used to provide short-term mechanical circulatory support1. The paper is succinct in highlighting all the systemic and device-related mechanical complications. The paper reports that the most common indication for Impella placement was in the setting of performance of a high-risk percutaneous coronary intervention (HRPCI). We want to highlight that the use of percutaneous left ventricular assist devices in HRPCI is based on very limited data. Results from the British Balloon Pump-Assisted Coronary Intervention Study (BCIS-1) showed ...
No takes yet. Share an insight, caveat, or question.
Chhabra et al. (2019) conducted a letter in High-risk percutaneous coronary intervention (HRPCI). Impella device was evaluated. Impella devices are associated with systemic and mechanical complications, and their use in high-risk percutaneous coronary intervention is based on very limited data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: